Company / R&D per Share
Protara Therapeutics, Inc. R&D per Share History
FY2014-FY2016 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$0.39
FY2016
5-year range
$0.24 / $24.62
FY2014-FY2016
Trend
+60.5%
vs FY2015
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $24.62 to $0.39 over the past 2 years.
Based on SEC 10-K filings.
0.39 in FY2016.
Declined from $24.62 to $0.39 over the past 2 years.
R&D per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2016, r&d per share increased 60.5% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.74 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2016 | $0.39 | +60.5% |
| FY2015 | $0.24 | -99.0% |
| FY2014 | $24.62 | - |
As of FY2016 · SEC 10-K · Updated Jun 28, 2026